Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia

NCT05776004 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia, Bacterial

Interventions

DRUG: CAL02
DRUG: Placebo

Sponsor

Eagle Pharmaceuticals, Inc.